Collagen fibrillar construction
US-9518106-B2 · Dec 13, 2016 · US
US10213523B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10213523-B2 |
| Application number | US-201414763860-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 4, 2014 |
| Priority date | Feb 4, 2013 |
| Publication date | Feb 26, 2019 |
| Grant date | Feb 26, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods and devices are described for using a controlled extensional strain to organize prefibrillar collagen and/or elastin solutions into an organized array of fibrils. The organized array of collagen fibrils produced by the disclosed methods and devices can be used for tissue engineering applications.
Opening claim text (preview).
What is claimed is: 1. A method of organizing prefibrillar solution into an organized array of fibrils comprising: providing a collagen and/or elastin solution, wherein the collagen and/or elastin are prefibrils; and creating a fluid flow through the prefibrillar solution by converging flow produced by hyperbolic contraction of the solution that produces a controlled extensional strain and shear strain to the collagen and/or elastin prefibrils, wherein the extensional and shear strain are sufficient to induce the prefibrils to assemble into an organized array of fibrils. 2. The method of claim 1 , wherein the solution further comprises fibronectin and/or proteoglycans. 3. The method of claim 1 , wherein a drawing probe generates the extensional strain. 4. The method of claim 1 , wherein the solution is in the form of a droplet, sheet, sphere, or cylinder. 5. The method of claim 1 , further comprising adding supplemental prefibrils to the solution during application of the strain. 6. The method of claim 1 , further comprising continuously extending a fibrillar structure at a rate of about 1 μm/second to about 1 mm/second. 7. The method of claim 1 , further comprising extending the organized array of fibrils in the presence of a co-nonsolvency agent. 8. The method of claim 1 , further comprising exposing the organized array of fibrils to a solution that promotes recrystallization. 9. The method of claim 8 , wherein the solution that promotes recrystallization is a buffer comprising a hypertonic agent. 10. The method of claim 9 , wherein the hypertonic agent is polyethylene glycol, hyaluronic acid, or glycosaminoglycans. 11. The method of claim 1 , further comprising applying tension to the organized array of fibrils as the fibrils recrystallize. 12. The method of claim 1 , wherein the total concentration of the collagen and/or elastin in the prefibrillar solution is about 1.2 mg/ml to about 500 mg/ml. 13. The method of claim 12 , wherein the total concentration of the collagen and/or elastin in the prefibrillar solution is about 2.4 mg/ml to about 100 mg/ml.
Use of proteins, e.g. casein, gelatine or derivatives thereof, as moulding material · CPC title
Collagen · CPC title
Shaping by stretching, e.g. drawing through a die; Apparatus therefor (B29C61/08 takes precedence) · CPC title
Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG] · CPC title
alpha-Glycoproteins · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.